RE:Are you skeptical about Biocloud?Great post. The people that dont believe havent dont thier homework. Which honestly is clearly A LOT OF PEOPLE! How this isnt a minimum $500M market cap is beyond me. Its allowed me and the investor group I am a part of the absolutely load up however so its not all bad. This stock is going to change all of your lives, keep buying as much as you can honestly.
Qrewpt wrote:
The risks to KNR's BioCloud always seemed to be 1. Does it work. 2. Does it get disrupted by Covid testing, 3. Does it get disrupted by vaccines 4. Can they get a large contract?
Having read streams of news over the last few weeks, and I'm finding BioCloud really is compelling. I've managed to appease the skeptic inside me.
1. Does it work...well aside from being validated by indpendant labs, they submitted results to the NRC ( federal government) then had 3 documented meetings with ministry officials...after which one minister re-tweeted an article about KNR's successful test results. Reading between the lines, I would say in all likelyhood the government believes that it works.
2. Covid testing apparently fails to detect Covid in subjects only recently infected. Need evidence? Read up on the spread of coronavirus through the White House. For those critical of BioCloud's published MSRP, how much does it cost for daily Covid tests? BioCloud is comparatively cheap, and addresses the issues with testing.
3. Vaccinations... Ok so it's pretty clear we aren't getting these for a while. When we do, we know they won't be 100% effective, we know there are plenty of anti vaxxers, and we are very uncertain about the durability of effectiveness, multiple doses, or periodic updates to the vaccine may be required similarly to flu shots. Regeneron says they can produce 200k antibody treatments next year, while not a vaccine, it tells me that there is no one silver bullet, no one company can produce enough vaccine soon enough.
4. Government Covid contracts....have a look at these extreme emergency government issued contracts for PPE ( facemasks and such), Inksmith $56m, Fluid Energy $100m, Steven Co. $79m, Canadian Emerg Ventilators $169m, FTIPG Inc $237m, Cae $282m, Medicom $113m ( they don't even have a factory yet.), and many more. The precedence is set, it wouldn't be a stretch by any means for KNR to receive a similar contract that gets the ball rolling.
So there are big gaps which need to be filled if we're to move on with our lives, and compellingly, BioCloud appears to be a key tool in helping us make that happen. It's crazy that you can still buy this stock at less than $150m market cap.